The best benefit population treated with lenvatinib plus anti-PD-1 for unresectable hepatocellular carcinoma.
JOURNAL OF CLINICAL ONCOLOGY(2022)
关键词
hepatocellular carcinoma,unresectable hepatocellular carcinoma,lenvatinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要